Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks

Tuberkuloz ve Toraks

Volumn 54, Issue 2, 2006, Pages 128-136

  Ediger, Dane ^a   Coşkun, Funda ^a   Kunt Uzaslan, Esra ^a   Gürdal Yüksel, Eser ^a   Karadaǧ, Mehmet ^a   Ege, Ercüment ^a   Gözü, Oktay ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Asthma attack; Budesonide; Efficacy; Nebulized; Systemic corticosteroid

Indexed keywords

BUDESONIDE; CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG FORMULATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MALE; NEBULIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SPIROMETRY; SUSPENSION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33747076029     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987; 136: 225-43.
2. Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma: National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland, USA. Publication no. 97-4051, July 1997.
3. Morice AH, Morris D, Lawson-Matthew PA. Comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbation of obstructive pulmonary disease. Clin Pharmacol Ther 1996; 60: 675-8.
4. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Rev Respir Crit Care Med 2002; 165: 698-703.
5. Beasley R, Sterk PJ, Kerstjens HA, Decramer M. Comparative studies of inhaled corticosteroids in asthma. Eur Respir J 2001; 17: 579-80.
6. Higenbottam TW, Britton J, Lawrence D, et al. Comparison of nebulized budesonide and prednisolone at severe asthma exacerbation in adults. Bio Drugs 2000; 14: 247-54.
7. O'Connell EJ. Review of the unique properties of budesonide. Clin Ther 2003; 25 (Suppl C): C42-60.
8. Devidayal D, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999; 88: 835-40.
9. Wennergren G, Nordvall SL, Hedlin G, et al. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr 1996; 85: 183-9.
10. Ilangovan P, Pedersen S, Godfrey S, et al. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child 1993; 68: 356-9.
11. Kemp JP, Skoner DP, Szefler SJ, et al. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol 1999; 83: 231-9.
12. Szefler SJ, Eigen H. Budesonide inhalation suspension: A nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol 2002; 109: 730-42.
13. Singhi SC, Banerjee S, Nanjundaswamy HM. Inhaled budesonide in acute asthma. J Paediatr Child Health 1999; 35: 483-7.
14. Nuhoglu Y, Bahceciler NN, Barlan IB, Mujdat Basaran M. The effectiveness of high dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol 2001; 86: 318-22.
15. Wilson AM, Mc Farlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest 1998; 114: 1022-7.
16. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med 1992; 86: 105-8.
17. Higenbottam TW, Clark RA, Luksza AR, et al. The role of nebulized budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res 1994; 5: 1-10.
18. O'Connor BJ, Basran GS, O'Connell F, O'Shaughnessy KM. Oral steroid sparing effect of nebulized budesonide in chronic severe asthma. Am J Respir Crit Care Med 1996; 153 (No 4 Pt 2): A341.
19. Hvizdos KM, Jarvis B. Budesonide inhalation suspension: A review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs 2000; 60: 1141-78.
20. Mitchell CA, Alpers JH, Morton SM, et al. Comparison of nebulized budesonide with oral prednisolone in the treatment of severe acute asthma. Eur Respir J 1995; 8 (Suppl 19): 490.
21. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: A randomized controlled trial. JAMA 1999; 281: 2119-26.
22. Rodrigo C, Rodrigo G. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998; 157: 698-703.
23. Rodrigo GJ, Rodrigo C. Triple inhaled drug protocol for the treatment of acute severe asthma. Chest 2003; 123: 1908-15.
24. McFadden ER. Inhaled corticosteroids and acute asthma: Therapeutic breakthrough or nonspecific effect? Am Rev Respir Crit Care Med 1998; 157: 677-8.